Enhabit (EHAB) Stock Forecast, Price Target & Predictions
EHAB Stock Forecast
Enhabit stock forecast is as follows: an average price target of $10.25 (represents a 37.40% upside from EHAB’s last price of $7.46) and a rating consensus of 'Hold', based on 5 wall street analysts offering a 1-year stock forecast.
EHAB Price Target
EHAB Analyst Ratings
Hold
Enhabit Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
May 14, 2024 | Whit Mayo | Leerink Partners | $8.50 | $8.64 | -1.62% | 13.94% |
Dec 08, 2022 | - | UBS | $12.00 | $13.99 | -14.22% | 60.86% |
10
Enhabit Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | 1 |
Avg Price Target | - | - | $8.50 |
Last Closing Price | $7.46 | $7.46 | $7.46 |
Upside/Downside | -100.00% | -100.00% | 13.94% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 14, 2024 | Leerink Partners | - | Market Perform | Upgrade |
May 09, 2024 | Jefferies | - | Hold | Downgrade |
Mar 07, 2024 | UBS | Sell | Neutral | Upgrade |
Aug 11, 2023 | Credit Suisse | Neutral | Neutral | Hold |
Dec 13, 2022 | CJS Securities | - | Market Perform | Initialise |
Dec 08, 2022 | UBS | - | Sell | Initialise |
Oct 13, 2022 | Oppenheimer | - | Perform | Initialise |
10
Enhabit Financial Forecast
Enhabit Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $260.60M | $258.30M | - | $265.10M | $275.10M | $265.70M | $268.00M |
Avg Forecast | $283.43M | $288.95M | $272.78M | $273.45M | $273.04M | $268.31M | $265.85M | $266.17M | $259.11M | $261.60M | $267.33M | $268.45M | $260.16M | $265.32M | $273.51M | $271.45M | $267.86M | $266.45M | $268.18M |
High Forecast | $291.71M | $297.39M | $280.74M | $281.44M | $281.02M | $276.14M | $273.61M | $274.19M | $272.48M | $262.09M | $267.33M | $268.45M | $263.76M | $265.39M | $281.50M | $279.38M | $275.68M | $266.45M | $268.18M |
Low Forecast | $275.06M | $280.42M | $264.72M | $265.38M | $264.98M | $260.38M | $257.99M | $258.13M | $248.93M | $261.11M | $267.33M | $268.45M | $257.29M | $265.26M | $265.44M | $263.43M | $259.95M | $266.45M | $268.18M |
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.97% | - | 0.98% | 1.03% | 1.00% | 1.00% |
Forecast
Enhabit EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $12.60M | $15.60M | - | $22.00M | $36.80M | $25.90M | $35.50M |
Avg Forecast | $22.61M | $23.05M | $21.76M | $21.82M | $21.78M | $21.40M | $21.21M | $21.23M | $20.67M | $20.87M | $21.33M | $21.42M | $20.75M | $21.17M | $21.82M | $21.66M | $21.37M | $31.50M | $163.30M |
High Forecast | $23.27M | $23.73M | $22.40M | $22.45M | $22.42M | $22.03M | $21.83M | $21.87M | $21.74M | $20.91M | $21.33M | $21.42M | $21.04M | $21.17M | $22.46M | $22.29M | $21.99M | $31.50M | $195.96M |
Low Forecast | $21.94M | $22.37M | $21.12M | $21.17M | $21.14M | $20.77M | $20.58M | $20.59M | $19.86M | $20.83M | $21.33M | $21.42M | $20.53M | $21.16M | $21.18M | $21.02M | $20.74M | $31.50M | $130.64M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.61% | 0.74% | - | 1.02% | 1.72% | 0.82% | 0.22% |
Forecast
Enhabit Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-6.40M | $-2.40M | - | $2.70M | $7.70M | $8.60M | $20.10M |
Avg Forecast | $3.60M | $7.75M | $5.38M | $5.27M | $3.81M | $2.34M | $3.18M | $3.14M | $2.72M | $1.97M | $2.86M | $2.33M | $1.27M | $3.05M | $6.77M | $7.72M | $11.67M | $14.50M | $20.92M |
High Forecast | $3.74M | $8.05M | $5.58M | $5.47M | $3.95M | $2.43M | $3.30M | $3.26M | $3.40M | $2.04M | $2.86M | $2.34M | $1.29M | $3.17M | $7.02M | $8.01M | $12.12M | $14.50M | $25.10M |
Low Forecast | $3.46M | $7.46M | $5.17M | $5.07M | $3.66M | $2.25M | $3.05M | $3.02M | $1.36M | $1.89M | $2.86M | $2.32M | $1.25M | $2.93M | $6.51M | $7.42M | $11.23M | $14.50M | $16.74M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.06% | -0.79% | - | 0.35% | 0.66% | 0.59% | 0.96% |
Forecast
Enhabit SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $114.50M | $108.80M | - | $110.50M | $106.50M | $107.50M | $102.20M |
Avg Forecast | $112.00M | $114.18M | $107.78M | $108.05M | $107.89M | $106.02M | $105.05M | $105.17M | $102.39M | $103.37M | $105.63M | $106.07M | $102.80M | $104.84M | $108.08M | $107.26M | $105.84M | $105.29M | $106.37M |
High Forecast | $115.27M | $117.51M | $110.93M | $111.21M | $111.04M | $109.12M | $108.11M | $108.34M | $107.67M | $103.56M | $105.63M | $106.07M | $104.22M | $104.87M | $111.23M | $110.39M | $108.93M | $105.29M | $127.65M |
Low Forecast | $108.69M | $110.80M | $104.60M | $104.86M | $104.70M | $102.89M | $101.94M | $102.00M | $98.36M | $103.17M | $105.63M | $106.07M | $101.67M | $104.81M | $104.88M | $104.09M | $102.72M | $105.29M | $85.10M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.11% | 1.04% | - | 1.03% | 1.01% | 1.02% | 0.96% |
Forecast
Enhabit EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 2 | 3 | 3 | 6 | 3 | 3 | 3 | 4 | 4 | 4 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.13 | $-0.05 | - | $0.05 | $0.15 | $0.17 | $0.41 |
Avg Forecast | $0.07 | $0.15 | $0.11 | $0.11 | $0.08 | $0.05 | $0.06 | $0.06 | $0.05 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.13 | $0.15 | $0.23 | $0.29 | $0.49 |
High Forecast | $0.07 | $0.16 | $0.11 | $0.11 | $0.08 | $0.05 | $0.07 | $0.06 | $0.07 | $0.04 | $0.06 | $0.05 | $0.03 | $0.06 | $0.14 | $0.16 | $0.24 | $0.29 | $0.49 |
Low Forecast | $0.07 | $0.15 | $0.10 | $0.10 | $0.07 | $0.04 | $0.06 | $0.06 | $0.03 | $0.04 | $0.06 | $0.05 | $0.02 | $0.06 | $0.13 | $0.15 | $0.22 | $0.29 | $0.49 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -5.15% | -0.79% | - | 0.33% | 0.65% | 0.59% | 0.84% |
Forecast
Enhabit Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ACHC | Acadia Healthcare Company | $39.10 | $82.33 | 110.56% | Buy |
HCSG | Healthcare Services Group | $11.39 | $17.33 | 52.15% | Hold |
INNV | InnovAge | $4.70 | $6.80 | 44.68% | Hold |
EHAB | Enhabit | $7.46 | $10.25 | 37.40% | Hold |
PNTG | Pennant Group | $30.78 | $34.67 | 12.64% | Buy |
ADUS | Addus HomeCare | $120.99 | $132.80 | 9.76% | Buy |
SEM | Select Medical | $38.09 | $40.00 | 5.01% | Buy |
ENSG | Ensign Group | $144.66 | $148.20 | 2.45% | Buy |
EHC | Encompass Health | $98.93 | $97.00 | -1.95% | Buy |